v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities    
Net income $ 111,549 $ 138,446
Adjustments to reconcile net income to net cash used in operating activities    
Depreciation and amortization 7,070 4,799
Amortization of lease right-of-use assets 7,847 3,573
Stock-based compensation 14,760 8,525
Deferred income tax benefit 6,871 9,406
Contingent consideration revaluation (11,606) 7,845
Payments of contingent consideration (20,263) (29,259)
Other, net 851 (3,702)
Changes in operating assets and liabilities, net of effects of acquisitions    
Accounts receivable (5,663) (2,129)
Inventories (169,879) (332,996)
Lot deposits (66,427) (52,351)
Other assets (30,602) (6,229)
Mortgage loans held for sale 151,132 0
Accounts payable and accrued liabilities (67,408) (51,721)
Customer deposits (41,431) (52,335)
Net cash used in operating activities (113,199) (358,128)
Cash flows from investing activities    
Purchase of property and equipment (13,470) (3,892)
Proceeds from disposals of property and equipment 191 67
Investments in unconsolidated entities (1,937) (1,562)
Return of investments from unconsolidated entities 1,086 0
Payments for acquisitions (183,104) (184,323)
Purchase of investment securities (2,022) 0
Proceeds from sales and maturities of investment securities 2,001 0
Net cash used in investing activities (197,255) (189,710)
Cash flows from financing activities    
Proceeds from revolving credit facility and other borrowings 791,141 460,620
Repayments on revolving credit facility and other borrowings (352,174) (100,128)
Proceeds from mortgage warehouse facilities 151,616 0
Repayments on mortgage warehouse facilities (296,946) 0
Payments of debt issuance costs (720) (6,982)
Payments of preferred stock dividends (6,750) (3,375)
Payments for common stock withheld for taxes (7,883) (12,464)
Repurchases of common stock (23,020) (1,846)
Distributions to noncontrolling interests (3,962) (11,980)
Payments of contingent consideration (22,270) (27,832)
Net cash provided by financing activities 229,032 296,013
Net decrease in cash, cash equivalents and restricted cash (81,422) (251,825)
Cash, cash equivalents and restricted cash at beginning of period 339,825 548,456
Cash, cash equivalents and restricted cash at end of period 258,403 296,631
Reconciliation of cash, cash equivalents and restricted cash    
Cash and cash equivalents 210,320 274,797
Restricted cash 48,083 21,834
Total cash, cash equivalents and restricted cash 258,403 296,631
Supplemental disclosures of cash payments:    
Cash paid for interest 126,758 87,847
Cash paid for income taxes, net of refunds [1] 91,107 105,991
Noncash investing activities    
Noncontrolling interests issued in business combinations [2] 8,088 21,451
Accrued cash consideration for business combinations [3] 6,712 26,126
Noncash financing activities    
Dividends accrued on preferred stock 0 3,375
Total noncash investing and financing activities $ 14,800 $ 50,952
[1] Includes payments for purchased tax credits of $5.7 million and $36.6 million related to 2025 and 2024 income tax expense, respectively, for the six months ended June 30, 2025. Includes payments for purchased tax credits of $2.1 million related to 2024 income tax expense for the six months ended June 30, 2024.
[2] Based on the estimated acquisition date fair value of the redeemable noncontrolling interests as of the reporting period date. Refer to Note 2, Acquisitions for more information.
[3] Includes $6.7 million in purchase price adjustments related to the Crescent Ventures, LLC (“Crescent Homes” or “Crescent”) acquisition. Refer to Note 2, Acquisitions for more information.